STERIS plc $STE Stock Sold by Aberdeen Group plc

Aberdeen Group plc trimmed its position in shares of STERIS plc (NYSE:STE – Free Report) by 84.4% during the 3rd quarter, Holdings Channel reports. The firm owned 13,232 shares of the medical equipment provider’s stock after selling 71,645 shares during the period. Aberdeen Group plc’s holdings in STERIS were worth $2,779,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Allworth Financial LP boosted its holdings in STERIS by 32.6% in the 3rd quarter. Allworth Financial LP now owns 2,443 shares of the medical equipment provider’s stock worth $514,000 after buying an additional 600 shares during the period. Fisher Asset Management LLC purchased a new stake in STERIS in the 3rd quarter worth $2,407,000. Eurizon Capital SGR S.p.A. raised its holdings in STERIS by 3.2% during the third quarter. Eurizon Capital SGR S.p.A. now owns 101,569 shares of the medical equipment provider’s stock valued at $21,331,000 after acquiring an additional 3,105 shares during the period. Fifth Third Bancorp raised its holdings in STERIS by 3.2% during the third quarter. Fifth Third Bancorp now owns 3,347 shares of the medical equipment provider’s stock valued at $703,000 after acquiring an additional 104 shares during the period. Finally, Maryland State Retirement & Pension System raised its holdings in STERIS by 23.7% during the third quarter. Maryland State Retirement & Pension System now owns 6,293 shares of the medical equipment provider’s stock valued at $1,322,000 after acquiring an additional 1,207 shares during the period. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. Weiss Ratings raised STERIS from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, November 9th. UBS Group decreased their target price on STERIS from $275.00 to $270.00 and set a “buy” rating on the stock in a research note on Friday, August 7th. Morgan Stanley raised STERIS from an “overweight” rating to a “buy” rating in a report on Friday, November 13th. Jefferies Financial Group upgraded STERIS from a “hold” rating to a “buy” rating and upped their price target for the stock from $232.00 to $305.00 in a research note on Friday, November 13th. Finally, Wall Street Zen raised shares of STERIS from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 14th. Five investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $283.50.

Get Our Latest Research Report on STE

Insiders Place Their Bets

In related news, VP Julia Madsen sold 2,046 shares of the stock in a transaction dated Friday, November 13th. The shares were sold at an average price of $260.00, for a total value of $531,960.00. Following the completion of the transaction, the vice president owned 10,211 shares of the company’s stock, valued at approximately $2,654,860. This trade represents a 16.69% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Karen L. Burton sold 5,880 shares of STERIS stock in a transaction dated Wednesday, November 11th. The stock was sold at an average price of $255.62, for a total value of $1,503,045.60. Following the completion of the transaction, the chief financial officer owned 12,956 shares of the company’s stock, valued at approximately $3,311,812.72. This represents a 31.22% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 12,819 shares of company stock valued at $3,274,011 in the last three months. Corporate insiders own 1.12% of the company’s stock.

STERIS Stock Up 0.4%

NYSE STE opened at $255.66 on Friday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.44 and a current ratio of 2.05. The company has a market capitalization of $24.83 billion, a P/E ratio of 24.05 and a beta of 0.86. STERIS plc has a one year low of $195.14 and a one year high of $269.44. The stock has a 50 day moving average price of $227.43 and a 200-day moving average price of $224.49.

STERIS (NYSE:STE – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The medical equipment provider reported $2.94 earnings per share for the quarter, topping the consensus estimate of $2.68 by $0.26. STERIS had a net margin of 13.41% and a return on equity of 14.80%. The company had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter in the previous year, the business posted $2.47 earnings per share. STERIS’s quarterly revenue was up 8.8% on a year-over-year basis. As a group, equities analysts predict that STERIS plc will post 11.46 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Tuesday, November 17th will be paid a $0.69 dividend. This represents a $2.76 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend is Tuesday, November 17th. STERIS’s dividend payout ratio (DPR) is presently 32.74%.

STERIS Profile

(Free Report)

STERIS plc (NYSE: STE) provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures. The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.

Featured Articles

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.